Filing Details
- Accession Number:
- 0000950170-23-071270
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-18 21:57:03
- Reporting Period:
- 2023-12-14
- Accepted Time:
- 2023-12-18 21:57:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1633932 | Essa Pharma Inc. | EPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1451935 | Ross David Parkinson | C/O Essa Pharma Inc. 999 West Broadway, Suite 720 Vancouver A1 V5Z 1K5 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2023-12-14 | 9,223 | $2.30 | 65,675 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.
Billionaire Hedge Funds
